Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2009; 53:445-451, doi:10.1016/j.jacc.2008.09.046
© 2009 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow View Related Cardiosource Journal Scan
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Protogerou, A.
Right arrow Articles by Safar, M. E.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Protogerou, A.
Right arrow Articles by Safar, M. E.
Related Collections
Right arrowRelated Articles

CLINICAL RESEARCH: HYPERTENSION

Blood Pressure Response Under Chronic Antihypertensive Drug Therapy

The Role of Aortic Stiffness in the REASON (Preterax in Regression of Arterial Stiffness in a Controlled Double-Blind) Study

Athanase Protogerou, MD*, Jacques Blacher, MD, PhD{dagger}, George S. Stergiou, MD*, Apostolos Achimastos, MD* and Michel E. Safar, MD{dagger},*

* Hypertension Center, Third Department of Medicine, Sotiria Hospital, University of Athens, Athens, Greece
{dagger} Paris-Descartes University, Faculty of Medicine, Hôtel-Dieu Hospital, AP-HP, Diagnosis Center, Paris, France

Manuscript received February 11, 2008; revised manuscript received September 4, 2008, accepted September 8, 2008.

* Reprint requests and correspondence: Prof. Michel Safar, Diagnosis Center, Hôpital Hôtel-Dieu, 1, place du Parvis Notre-Dame, 75181 Paris Cedex 04, France (Email: michel.safar{at}htd.aphp.fr).

Objectives: We sought to evaluate the role of arterial stiffness on blood pressure (BP) response to drug treatment.

Background: Increased arterial stiffness (pulse wave velocity [PWV]) is associated with increased systolic blood pressure (SBP). Antihypertensive drug therapy achieves better control of diastolic blood pressure (DBP) than SBP does, implying that increased PWV might be a predictor of the SBP response to treatment.

Methods: The REASON (Preterax in Regression of Arterial Stiffness in a Controlled Double-Blind) study is a randomized, double-blind trial comparing atenolol versus perindopril/indapamide; 375 patients with hypertension, with BP and PWV measurements at baseline and after 12 months of treatment, were divided into 3 tertiles according to baseline PWV and included in a post-hoc analysis.

Results: After 12 months of treatment, BP differed significantly between PWV tertiles (the third having the lowest response, p < 0.05). Factors related to smaller BP decline were low baseline BP, high baseline PWV, need for a double dose of treatment, use of atenolol (only for SBP response), and age (only for DBP). Although DBP control did not differ in the PWV tertiles, SBP control was significantly associated with PWV level (p = 0.001) as well as with the use of perindopril/indapamide (p < 0.001). The predictive value of PWV on BP response was independent of age, sex, mean BP, and cardiovascular risk factors.

Conclusions: Baseline PWV is a significant predictor of BP response to antihypertensive treatment, independent from age, the need for increasing drug dosage, and the presence of cardiovascular risk factors. Achievement of SBP control appears to be influenced by aortic stiffness as well as by angiotensin-converting enzyme inhibition.

Key Words: arterial stiffness • pulse wave velocity • antihypertensive therapy

Abbreviations and Acronyms
  ACEI = angiotensin-converting enzyme inhibitor
  BMI = body mass index
  BP = blood pressure
  CF = carotid-femoral
  CV = cardiovascular
  DBP = diastolic blood pressure
  MAP = mean arterial pressure
  Per/Ind = perindopril/indapamide
  PWV = pulse wave velocity
  SBP = systolic blood pressure


Related Articles

The Aorta and Resistant Hypertension
Bryan Williams
J. Am. Coll. Cardiol. 2009 53: 452-454. [Full Text] [PDF]

Inside This Issue
J. Am. Coll. Cardiol. 2009 53: A32. [Full Text] [PDF]



This article has been cited by other articles:


Home page
HypertensionHome page
M. E. Safar, A. Protogerou, and J. Blacher
Central Blood Pressure Under Angiotensin and Calcium Channel Blockade
Hypertension, October 1, 2009; 54(4): 704 - 706.
[Full Text] [PDF]


Home page
HypertensionHome page
I. S. Mackenzie, C. M. McEniery, Z. Dhakam, M. J. Brown, J. R. Cockcroft, and I. B. Wilkinson
Comparison of the Effects of Antihypertensive Agents on Central Blood Pressure and Arterial Stiffness in Isolated Systolic Hypertension
Hypertension, August 1, 2009; 54(2): 409 - 413.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
B. Williams
The aorta and resistant hypertension.
J. Am. Coll. Cardiol., February 3, 2009; 53(5): 452 - 454.
[Full Text] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement